Kelun-Biotech reports fourth indication for sac-TMT approved by NMPA in HR+/HER2- breast cancer

Innovent Biologics collaborates with Eli Lilly to develop new oncology and immunology treatments

K36 Therapeutics completes first patient cohort dosing for Phase 1 trial of KTX-2001

Partner Therapeutics' zenocutuzumab-zbco granted US FDA Orphan Drug Designation for treatment of cholangiocarcinoma

Hologic receives FDA approval for Aptima HPV assay as primary screening option

Cizzle Biotechnology secures Canadian patent for lung cancer biomarker test

Biosion reports first patient dosed in Phase 1a/1b trial of BSI-082

Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment

DATROWAY receives US priority review for first-line metastatic triple negative breast cancer

Natera submits Signatera CDx PMA to FDA for bladder cancer use

Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer

I Peace generates human iPS cells from NKT cells and offers them for research use

Frontage expands early phase clinical research capabilities across US and China

Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA

InSysBio agrees new collaborative project with BeOne Medicines